Evaluation of the salivary biomarker cortisol in patients with temporomandibular disorders
Journal of Oral & Facial Pain and Headache · 2026
DOI: 10.22514/jofph.2026.007 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Oral & Facial Pain and Headache, 2026. Verfasst von Bruno Macedo de Sousa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Occlusion and Orofacial Pain, Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal. Hauptthemen laut MEDLINE: Hydrocortisone, Saliva, Temporomandibular Joint Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Temporomandibular Disorders (TMD) are musculoskeletal and neuro-muscular conditions involving the temporomandibular joint (TMJ), masticatory muscles, and related structures. Stress can trigger dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to increased cortisol secretion. Salivary cortisol assessment provides a non-invasive method to investigate this relationship.
Methods
A total of 98 participants were recruited—49 patients diagnosed with TMD and 49 healthy controls—at the Faculty of Medicine of the University of Coimbra. Participants were evaluated according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). Saliva samples were collected between 9:00 and 11:00 AM, processed with Enzyme-Linked Immunosorbent Assay (ELISA), and analyzed statistically using Shapiro-Wilk and Mann-Whitney tests, with a 95% confidence level.
Results
Salivary cortisol levels were significantly higher in TMD patients (mean = 17.55 nmol/L) compared with controls (mean = 11.09 nmol/L; p = 0.0032). No significant correlations were found between age and cortisol levels.
Conclusions
Patients with TMD present higher salivary cortisol levels, suggesting dysregulation of the HPA axis associated with stress. These findings support the integration of psychosocial factors into the management of TMD. Clinical Trial Registration: ClinicalTrials.gov identifier NCT06874868.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Occlusion and Orofacial Pain, Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal.
- Department of Surgery, University of Salamanca, 37007 Salamanca, Spain.
- Biomedical Research Intitute of Salamanca (IBSAL), 37007 Salamanca, Spain.
Zitieren
APA
Macedo de Sousa, B., Lopez-Valverde, N., Cardoso, C., Lopez-Valverde, A., Rodrigues, M. J., & Blanco Rueda, J. A. (2026). Evaluation of the salivary biomarker cortisol in patients with temporomandibular disorders. Journal of Oral & Facial Pain and Headache. https://doi.org/10.22514/jofph.2026.007
Vancouver
Macedo de Sousa B, Lopez-Valverde N, Cardoso C, Lopez-Valverde A, Rodrigues MJ, Blanco Rueda JA. Evaluation of the salivary biomarker cortisol in patients with temporomandibular disorders. Journal of Oral & Facial Pain and Headache. 2026. doi:10.22514/jofph.2026.007
BibTeX
@article{MacedodeSousa2026,
author = {Macedo de Sousa, Bruno and Lopez-Valverde, Nansi and Cardoso, Carla and Lopez-Valverde, Antonio and Rodrigues, Maria J and Blanco Rueda, Jose A},
title = {Evaluation of the salivary biomarker cortisol in patients with temporomandibular disorders},
journal = {Journal of Oral & Facial Pain and Headache},
year = {2026},
doi = {10.22514/jofph.2026.007}
}
EUVIMED